NCT03948568 2022-09-30
REaCT-RETT
Ottawa Hospital Research Institute
Phase 4 Completed
Clinical Trials
10 trialsNCT03220178 2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4 Terminated
NCT01176916 2021-10-27
AromasinĀ® Interventional Study Of Early Invasive Breast Cancer Patients In China
Pfizer
Phase 4 Completed
NCT01743560 2019-07-18
4EVERUK
Novartis
Phase 4 Completed
NCT03238703 2018-12-27
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Fred Hutchinson Cancer Center
Phase 4 Withdrawn
NCT01612871 2018-03-05
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT01127295 2018-03-02
PHACS
Institut Claudius Regaud
Phase 4 Completed
NCT02248571 2017-11-13
IMPROVE
iOMEDICO AG
Phase 4 Completed
NCT01553903 2013-06-04
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT00649090 2008-09-29
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer
Pfizer
Phase 4 Completed